Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Patrick Adelin Oscar Robberecht
Introduction
Patrick Adelin Oscar Robberecht is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of cytokine production inhibition. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Robberecht holds a patent for a method aimed at inhibiting cytokine production by cells, specifically animal or human cells. The invention involves applying at least one azo compound derivative, which corresponds to a specific chemical formula. This method is crucial for controlling cytokine secretion, which can have profound effects on inflammatory responses in the body. He has 1 patent to his name.
Career Highlights
Robberecht is associated with Previsan AG, a company that focuses on innovative solutions in the biotechnology sector. His work at Previsan AG has allowed him to explore and develop methods that can potentially lead to breakthroughs in medical treatments.
Collaborations
Throughout his career, Robberecht has collaborated with esteemed colleagues such as Michel Goldman and Hélène Margery. These partnerships have enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Patrick Adelin Oscar Robberecht exemplifies the spirit of innovation in biotechnology. His contributions, particularly in cytokine production inhibition, highlight the critical role of inventors in advancing medical science.